TXG
10x Genomics, Inc.$55.02-3.16 (-5.43%)Prev Close$58.19·MCap$7.07B·P/E—·Vol1.83M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
24
$17.98M
◆
Net Activity
Net Seller
$17.98M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at 10x Genomics, Inc. (TXG) has been exclusively selling, with 0 insider purchases totaling $0.00 and 24 insider sales totaling $17.98M. The most recent insider transaction was by Saxonov Serge (director, officer: Chief Executive Officer), who sold $1.95M worth of shares on Nov 13, 2026. 10x Genomics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $7.07B.
TXG Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 31,000 | $62.90 | $1.95M | 1,019,249 |
| Sep 24, 2026 | SULIMAN SHEHNAAZ | director | Sell | 5,723 | $81.19 | $464.7K | 29,223 |
| Sep 24, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 25,000 | $81.22 | $2.03M | 1,074,249 |
| Sep 11, 2026 | Taich Adam | officer: Chief Financial Officer | Sell | 46,388 | $64.57 | $3.00M | 361,526 |
| Sep 8, 2026 | STUELPNAGEL JOHN R | director | Sell | 20,000 | $61.75 | $1.24M | 341,424 |
| Aug 28, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 10,486 | $63.69 | $667.9K | 1,082,335 |
| Aug 26, 2026 | SULIMAN SHEHNAAZ | director | Sell | 2,207 | $63.65 | $140.5K | 31,161 |
| Aug 26, 2026 | Taich Adam | officer: Chief Financial Officer | Sell | 17,166 | $63.02 | $1.08M | 362,732 |
| Aug 26, 2026 | Hindson Benjamin J. | director, officer: See Remarks | Sell | 13,818 | $63.02 | $870.9K | 488,182 |
| Aug 26, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 18,545 | $63.02 | $1.17M | 1,085,835 |
| Aug 17, 2026 | Teichmann Sarah A. | director | Sell | 7,551 | $57.25 | $432.3K | 30,331 |
| Aug 13, 2026 | STUELPNAGEL JOHN R | director | Sell | 20,000 | $57.75 | $1.16M | 351,436 |
| Jun 24, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 30,000 | $34.44 | $1.03M | 1,129,853 |
| Jun 18, 2026 | SULIMAN SHEHNAAZ | director | Sell | 5,723 | $32.63 | $186.8K | 32,086 |
| May 27, 2026 | Taich Adam | officer: Chief Financial Officer | Sell | 15,098 | $24.44 | $369.0K | 379,898 |
| May 27, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 28,893 | $24.54 | $709.1K | 1,149,098 |
| May 27, 2026 | Hindson Benjamin J. | director, officer: See Remarks | Sell | 11,595 | $24.44 | $283.4K | 502,000 |
| Apr 16, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 5,000 | $24.56 | $122.8K | 1,167,273 |
| Mar 25, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 15,000 | $19.26 | $288.9K | 1,177,273 |
| Feb 27, 2026 | Teichmann Sarah A. | director | Sell | 7,579 | $19.41 | $147.1K | 26,780 |
| Feb 25, 2026 | Hindson Benjamin J. | director, officer: See Remarks | Sell | 7,826 | $18.58 | $145.4K | 424,779 |
| Feb 25, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 9,632 | $18.58 | $178.9K | 1,061,924 |
| Feb 25, 2026 | Taich Adam | officer: Chief Financial Officer | Sell | 8,968 | $18.58 | $166.6K | 288,417 |
| Nov 24, 2025 | Hindson Benjamin J. | See Remarks | Sell | 8,283 | $19.00 | $157.4K | 0 |
| Aug 22, 2025 | Taich Adam | Chief Financial Officer | Sell | 22,315 | $13.79 | $307.7K | 0 |
| May 22, 2025 | Saxonov Serge | Chief Executive Officer | Sell | 9,343 | $8.30 | $77.5K | 0 |
| May 22, 2025 | Taich Adam | Chief Financial Officer | Sell | 4,044 | $8.30 | $33.6K | 0 |
| Feb 24, 2025 | Hindson Benjamin J. | See Remarks | Sell | 4,573 | $11.07 | $50.6K | 0 |
| Feb 21, 2025 | MATEO ALAN | Director | Buy | 40,000 | $11.14 | $445.6K | 0 |
| Aug 26, 2024 | Hindson Benjamin J. | See Remarks | Sell | 4,351 | $22.53 | $98.0K | 345,704 |
| Aug 26, 2024 | McAnear Justin J. | Sell | 2,961 | $22.53 | $66.7K | 143,242 | |
| Aug 26, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 6,749 | $22.53 | $152.1K | 882,467 |
| May 23, 2024 | Hindson Benjamin J. | See Remarks | Sell | 4,087 | $24.30 | $99.3K | 350,055 |
| May 23, 2024 | McAnear Justin J. | Chief Financial Officer | Sell | 2,936 | $24.30 | $71.4K | 146,203 |
| May 23, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 4,877 | $24.30 | $118.5K | 889,641 |
| Mar 6, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 4,660 | $44.00 | $205.0K | 842,900 |
| Feb 26, 2024 | Hindson Benjamin J. | See Remarks | Sell | 2,613 | $46.34 | $121.1K | 283,059 |
| Feb 26, 2024 | McAnear Justin J. | Chief Financial Officer | Sell | 1,865 | $46.34 | $86.4K | 95,240 |
| Feb 26, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 2,821 | $46.34 | $130.7K | 847,560 |
| Feb 20, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 5,000 | $48.87 | $244.3K | 852,081 |
| Feb 13, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 1,000 | $49.53 | $49.5K | 855,381 |
| Jan 18, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 4,000 | $45.24 | $181.0K | 857,416 |
| Dec 18, 2023 | Saxonov Serge | Chief Executive Officer | Sell | 2,000 | $55.03 | $110.1K | 847,146 |
| Nov 27, 2023 | Hindson Benjamin J. | See Remarks | Sell | 3,449 | $43.34 | $149.5K | 277,338 |
| Nov 27, 2023 | McAnear Justin J. | Chief Financial Officer | Sell | 1,679 | $43.34 | $72.8K | 97,105 |
| Nov 27, 2023 | Saxonov Serge | Chief Executive Officer | Sell | 7,480 | $43.52 | $325.6K | 851,169 |
| Nov 27, 2023 | Wilbur James | Chief Commercial Officer | Sell | 3,464 | $43.34 | $150.1K | 83,342 |
| Nov 22, 2023 | Wilbur James | Chief Commercial Officer | Sell | 14,718 | $42.09 | $619.5K | 86,806 |
| Nov 16, 2023 | Saxonov Serge | Chief Executive Officer | Sell | 2,000 | $39.52 | $79.0K | 854,926 |
| Oct 18, 2023 | Saxonov Serge | Chief Executive Officer | Sell | 2,000 | $39.51 | $79.0K | 858,905 |
Showing 1–50 of 177
1 / 4
TXG Insider Buying Activity
The following table shows recent insider purchases of 10x Genomics, Inc. (TXG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | MATEO ALAN | Director | Buy | 40,000 | $11.14 | $445.6K | 0 |
TXG Insider Selling Activity
The following table shows recent insider sales of 10x Genomics, Inc. (TXG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 31,000 | $62.90 | $1.95M | 1,019,249 |
| Sep 24, 2026 | SULIMAN SHEHNAAZ | director | Sell | 5,723 | $81.19 | $464.7K | 29,223 |
| Sep 24, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 25,000 | $81.22 | $2.03M | 1,074,249 |
| Sep 11, 2026 | Taich Adam | officer: Chief Financial Officer | Sell | 46,388 | $64.57 | $3.00M | 361,526 |
| Sep 8, 2026 | STUELPNAGEL JOHN R | director | Sell | 20,000 | $61.75 | $1.24M | 341,424 |
| Aug 28, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 10,486 | $63.69 | $667.9K | 1,082,335 |
| Aug 26, 2026 | SULIMAN SHEHNAAZ | director | Sell | 2,207 | $63.65 | $140.5K | 31,161 |
| Aug 26, 2026 | Taich Adam | officer: Chief Financial Officer | Sell | 17,166 | $63.02 | $1.08M | 362,732 |
| Aug 26, 2026 | Hindson Benjamin J. | director, officer: See Remarks | Sell | 13,818 | $63.02 | $870.9K | 488,182 |
| Aug 26, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 18,545 | $63.02 | $1.17M | 1,085,835 |
| Aug 17, 2026 | Teichmann Sarah A. | director | Sell | 7,551 | $57.25 | $432.3K | 30,331 |
| Aug 13, 2026 | STUELPNAGEL JOHN R | director | Sell | 20,000 | $57.75 | $1.16M | 351,436 |
| Jun 24, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 30,000 | $34.44 | $1.03M | 1,129,853 |
| Jun 18, 2026 | SULIMAN SHEHNAAZ | director | Sell | 5,723 | $32.63 | $186.8K | 32,086 |
| May 27, 2026 | Taich Adam | officer: Chief Financial Officer | Sell | 15,098 | $24.44 | $369.0K | 379,898 |
| May 27, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 28,893 | $24.54 | $709.1K | 1,149,098 |
| May 27, 2026 | Hindson Benjamin J. | director, officer: See Remarks | Sell | 11,595 | $24.44 | $283.4K | 502,000 |
| Apr 16, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 5,000 | $24.56 | $122.8K | 1,167,273 |
| Mar 25, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 15,000 | $19.26 | $288.9K | 1,177,273 |
| Feb 27, 2026 | Teichmann Sarah A. | director | Sell | 7,579 | $19.41 | $147.1K | 26,780 |
| Feb 25, 2026 | Hindson Benjamin J. | director, officer: See Remarks | Sell | 7,826 | $18.58 | $145.4K | 424,779 |
| Feb 25, 2026 | Saxonov Serge | director, officer: Chief Executive Officer | Sell | 9,632 | $18.58 | $178.9K | 1,061,924 |
| Feb 25, 2026 | Taich Adam | officer: Chief Financial Officer | Sell | 8,968 | $18.58 | $166.6K | 288,417 |
| Nov 24, 2025 | Hindson Benjamin J. | See Remarks | Sell | 8,283 | $19.00 | $157.4K | 0 |
| Aug 22, 2025 | Taich Adam | Chief Financial Officer | Sell | 22,315 | $13.79 | $307.7K | 0 |
| May 22, 2025 | Saxonov Serge | Chief Executive Officer | Sell | 9,343 | $8.30 | $77.5K | 0 |
| May 22, 2025 | Taich Adam | Chief Financial Officer | Sell | 4,044 | $8.30 | $33.6K | 0 |
| Feb 24, 2025 | Hindson Benjamin J. | See Remarks | Sell | 4,573 | $11.07 | $50.6K | 0 |
| Aug 26, 2024 | Hindson Benjamin J. | See Remarks | Sell | 4,351 | $22.53 | $98.0K | 345,704 |
| Aug 26, 2024 | McAnear Justin J. | Sell | 2,961 | $22.53 | $66.7K | 143,242 | |
| Aug 26, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 6,749 | $22.53 | $152.1K | 882,467 |
| May 23, 2024 | Hindson Benjamin J. | See Remarks | Sell | 4,087 | $24.30 | $99.3K | 350,055 |
| May 23, 2024 | McAnear Justin J. | Chief Financial Officer | Sell | 2,936 | $24.30 | $71.4K | 146,203 |
| May 23, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 4,877 | $24.30 | $118.5K | 889,641 |
| Mar 6, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 4,660 | $44.00 | $205.0K | 842,900 |
| Feb 26, 2024 | Hindson Benjamin J. | See Remarks | Sell | 2,613 | $46.34 | $121.1K | 283,059 |
| Feb 26, 2024 | McAnear Justin J. | Chief Financial Officer | Sell | 1,865 | $46.34 | $86.4K | 95,240 |
| Feb 26, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 2,821 | $46.34 | $130.7K | 847,560 |
| Feb 20, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 5,000 | $48.87 | $244.3K | 852,081 |
| Feb 13, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 1,000 | $49.53 | $49.5K | 855,381 |
| Jan 18, 2024 | Saxonov Serge | Chief Executive Officer | Sell | 4,000 | $45.24 | $181.0K | 857,416 |
| Dec 18, 2023 | Saxonov Serge | Chief Executive Officer | Sell | 2,000 | $55.03 | $110.1K | 847,146 |
| Nov 27, 2023 | Hindson Benjamin J. | See Remarks | Sell | 3,449 | $43.34 | $149.5K | 277,338 |
| Nov 27, 2023 | McAnear Justin J. | Chief Financial Officer | Sell | 1,679 | $43.34 | $72.8K | 97,105 |
| Nov 27, 2023 | Saxonov Serge | Chief Executive Officer | Sell | 7,480 | $43.52 | $325.6K | 851,169 |
| Nov 27, 2023 | Wilbur James | Chief Commercial Officer | Sell | 3,464 | $43.34 | $150.1K | 83,342 |
| Nov 22, 2023 | Wilbur James | Chief Commercial Officer | Sell | 14,718 | $42.09 | $619.5K | 86,806 |
| Nov 16, 2023 | Saxonov Serge | Chief Executive Officer | Sell | 2,000 | $39.52 | $79.0K | 854,926 |
| Oct 18, 2023 | Saxonov Serge | Chief Executive Officer | Sell | 2,000 | $39.51 | $79.0K | 858,905 |
TXG Insiders
Similar Stocks to TXG
VRTX
Vertex Pharmaceuticals Incorporated
$536.14-0.42%
$138.69B
REGN
Regeneron Pharmaceuticals, Inc.
$948.88-0.62%
$99.23B
MRNA
Moderna, Inc.
$214.97-3.55%
$93.61B
RVMD
Revolution Medicines, Inc.
$166.45-3.42%
$39.08B
INSM
Insmed Incorporated
$122.96+1.38%
$26.58B
UTHR
United Therapeutics Corporation
$585.50-0.96%
$25.18B
INCY
Incyte Corporation
$120.12-0.66%
$24.66B
ALNY
Alnylam Pharmaceuticals, Inc.
$159.51-3.31%
$21.41B